Skip to main content
Top
Literature
2.
go back to reference Kishabongo AS, Katchunga P, Van Aken EH, Speeckaert R, Lagniau S, Coopman R, et al. Glycation of nail proteins: from basic biochemical findings to a representative Marker for diabetic glycation-associated target organ damage. PLoS One. 2015;10:e0120112.CrossRefPubMedCentralPubMed Kishabongo AS, Katchunga P, Van Aken EH, Speeckaert R, Lagniau S, Coopman R, et al. Glycation of nail proteins: from basic biochemical findings to a representative Marker for diabetic glycation-associated target organ damage. PLoS One. 2015;10:e0120112.CrossRefPubMedCentralPubMed
3.
go back to reference Delanghe S, Delanghe JR, Van Biesen W, Speeckaert R, Van Biesen W, Speeckaert MM. Mechanisms and consequences of carbamylation. Nat Rev Nephrol. 2017;13:580–93.CrossRefPubMed Delanghe S, Delanghe JR, Van Biesen W, Speeckaert R, Van Biesen W, Speeckaert MM. Mechanisms and consequences of carbamylation. Nat Rev Nephrol. 2017;13:580–93.CrossRefPubMed
4.
go back to reference Weyer L, Lo SC. Spectra-structure correlations in the near infra red. In: Chalmers JM, Griffiths PR, editors. Handbook of vibrational spectroscopy, vol. 3. Hoboken: Wiley; 2002. p. 1817–37. Weyer L, Lo SC. Spectra-structure correlations in the near infra red. In: Chalmers JM, Griffiths PR, editors. Handbook of vibrational spectroscopy, vol. 3. Hoboken: Wiley; 2002. p. 1817–37.
Metadata
Title
On the nature of toenail opacities in renal insufficiency
Authors
Sigurd Delanghe
Marijn Speeckaert
Sander De Bruyne
Joris Delanghe
Publication date
01-01-2019
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 1/2019
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1576-0

Other articles of this Issue 1/2019

Clinical and Experimental Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.